Speaker: FDA
FDA
has 59% among speakers.
BS Score: 42.8%.
Articles analyzed: 5.
Words analyzed: 50.333.
Analyzed articles
KFF Health News
- By David Hilzenrath, Holly K. Hacker
- 7/2/2026, 9:00 AM
Appeal to Authority 21% - Self-Serving Bias 18% - Negativity Bias 10.7%
In September 2016, a distraught mother sent infant formula maker Mead Johnson a message: “REMOVE ME FROM YOUR LIST!!!! DO NOT EMAIL OR MAIL ME ANY MORE! “It is because of your animal based pre-term artificial baby food crap that you peddle to hospital NICU’s that my son is dead from NEC.” more
PolitiFact
- By Madison Czopek
- 6/25/2026, 12:00 AM
Framing Effect 21.1% - Appeal to Authority 11.7% - Halo Effect 10.9%
The U.S. is one step closer to selling sunscreen products similar to those you might find in cosmetics stores across Europe, Australia and parts of Asia. More than 20 years after chemical manufacturer DSM Nutritional Products first applied for approval, the U.S. Food and Drug Administration gave the go-ahead to an active sunscreen... more
Snopes.com
- By Aleksandra Wrona
- 5/25/2026, 3:00 PM
Hasty Generalization 33.4% - Appeal to Authority 22.5% - Negativity Bias 20.3%
In May 2026, online ads and videos were again using Bill Gates' name to sell supposed remedies for Alzheimer's disease and dementia. The products appeared under names such as "Brain Honey," "Mind Boost," "Memopezil," "BrainHealth" and "MemoPryl," but the pitch stayed largely the same, presenting Gates as the person behind a memory-loss... more
The Guardian
- By Sarah Sloat
- 5/19/2026, 4:00 PM
Appeal to Authority 39.3% - Negativity Bias 12.9% - Indoctrination 11.7%
Do you think you’re not getting enough protein? Debbie Fetter, an associate professor in nutrition at the University of California, Davis, likes to ask her students this same question. In a lecture hall of more than 500 people, “almost every hand shoots up”, she says. Protein is top of mind for consumers. A 2024 survey of 3,000 Americans... more
Forbes
- By Alex Knapp
- 5/6/2026, 4:00 PM
Halo Effect 14.9% - Appeal to Authority 14.9% - Optimism Bias 14.7%
A clinical trial for the use of microrobots in treating Alzheimer’s disease kicked off with its first robotic-assisted procedure in human patients at Baptist Health in Jacksonville, Florida. The first patient, treated on Thursday, had moderate Alzheimer’s disease–the dementia that leads to devastating memory loss and affects 7 million... more